BAX · Baxter International Inc.
$16.682026-05-17Sector: Healthcare; Industry: Medical - Instruments & Supplies; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$0
-123.3% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($-4 · $-9) Analysts Range ($15 · $25) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $12.1B | — | 11.1% | 12.3% | $1.2B | −$10.5B | −$9.3B | 5.3% | — | 4.9% | $23.9B | $2.50 | — |
| 2022.Q4 | $10.1B | -17.2% | -28.3% | 0.0% | −$2.9B | −$493MM | −$3.4B | 12.7% | — | -12.9% | $20.9B | $-4.73 | — |
| 2023.Q4 | $10.4B | 3.0% | 6.8% | 45.0% | $389MM | $799MM | $1.2B | 6.4% | — | 1.9% | $19.2B | $5.17 | — |
| 2024.Q4 | $10.6B | 2.7% | 0.1% | 0.0% | $16MM | $504MM | $520MM | 17.4% | — | 0.1% | $18.4B | $-1.26 | — |
| 2025.Q4 | $11.2B | 5.7% | -2.7% | 0.0% | −$549MM | $351MM | −$198MM | 17.3% | — | -3.4% | $13.7B | $-1.86 | — |
| italics below = DCF projection · 10yr Rev CAGR: 3.4% |
| 2026.Q4 | $11.4B | +1.0% | -2.2% | 2.0% | −$241MM | −$139MM | −$380MM | 13.5% | −$335MM | -1.8% | $13.8B | $-0.47 | — |
| 2027.Q4 | $11.6B | +2.3% | -2.3% | 4.0% | −$254MM | −$339MM | −$594MM | 13.0% | −$463MM | -1.8% | $14.2B | $-0.50 | — |
| 2028.Q4 | $12.0B | +3.1% | -2.3% | 6.0% | −$258MM | −$490MM | −$748MM | 12.6% | −$518MM | -1.8% | $14.7B | $-0.50 | — |
| 2029.Q4 | $12.4B | +3.7% | -2.3% | 8.0% | −$261MM | −$615MM | −$876MM | 12.1% | −$541MM | -1.7% | $15.3B | $-0.51 | — |
| 2030.Q4 | $12.9B | +3.9% | -2.3% | 10.0% | −$266MM | −$699MM | −$964MM | 11.6% | −$534MM | -1.7% | $16.0B | $-0.52 | — |
|
| Term. Yr+ | $16.3B | 4.1% | 17.8% | 20.0% | $2.3B | −$1.1B | $1.2B | 8.6% | $9.4B | 8.8% | — | — | — |
Active scenario IV: $0 (-123.3% vs market)